DeepCell

Where AI meets living cells

Employees
51–200
Founded
2017
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Series ADec 2020
Rounds
1

About

DeepCell is a life sciences technology company that has developed the REM-I platform — an integrated system combining label-free imaging, deep learning AI, and gentle cell enrichment to analyze and sort living cells based on their morphology. The platform enables researchers and clinicians to profile single cells without fluorescent labels or destructive preparation, revealing high-dimensional biological insights invisible to conventional methods. Key application areas include oncology (tumor heterogeneity, rare cell sorting), drug discovery (phenotypic screening, mechanism of action), and cell and gene therapy (quality control, manufacturing). DeepCell is headquartered in Menlo Park, California.

Tech & App Stack

Tech & App Stack is available on paid plans

Upgrade to Silver or higher to reveal the full technology and app stack for any company.

View pricing

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Create Free Account

Funding History

Series ASeries ADec 2020
$20.0M

Investors

Sign up to view investors

Create a free account to see which investors have funded this company.

Create Free Account

Similar Companies